생명과학회지 (Journal of Life Science)

  • 제27권7호
  • /
  • Pages.834-839
  • /
  • 2017
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

상피성 난소암 세포에서 프로폴리스 추출물의 세포 증식 저해 효과

Growth Inhibitory Effect of Extracts of Propolis on Epithelial Ovarian Cancer Cells

  • 양가람 (부산대학교 한의학전문대학원) ;
  • 윤경미 (부산대학교 한의학전문대학원) ;
  • 오현호 (부산대학교 한의학전문대학원) ;
  • 김민성 (부산대학교 해양생물기술연구소) ;
  • 황태호 (부산대학교 의학전문대학원 약리학교실) ;
  • 안원근 (부산대학교 한의학전문대학원)
  • Yang, Ga Ram (School of Korean Medicine, Pusan National University) ;
  • Yoon, Kyung Mi (School of Korean Medicine, Pusan National University) ;
  • Oh, Hyun Ho (School of Korean Medicine, Pusan National University) ;
  • Kim, Min Sung (Institute of Marine BioTechnology Pusan National University) ;
  • Hwang, Tae Ho (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • An, Won Gun (School of Korean Medicine, Pusan National University)
  • 투고 : 2017.06.09
  • 심사 : 2017.07.24
  • 발행 : 2017.07.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Propolis는 꿀벌들이 나무로부터 수집한 천연물로서 항산화, 항염증, 항암 효과를 가지고 있어 전통의학에서 사용되고 있으며, 이러한 생리활성은 여러 가지 유용성분들이 혼합된 것과 관련이 있다. 난소암은 우리나라 여성에서 두 번째로 발병률이 높은 암이다. 대부분의 난소암 환자들은 초기에 수술적 기법과 항암요법에 우수하게 반응하지만, 항암제 내성에 의한 재발이 발생하게 되면 항암요법제에 의한 반응률이 매우 저조하여 높은 사망률을 보인다. 따라서, 난소암의 높은 치사율을 극복하기 위한 새로운 치료제 및 항암보조제의 개발이 필요하다. 본 연구에서는 인체 상피성 난소암 세포주인 A2780를 이용하여 Austalian propolis의 항암 효과와 활성기전을 조사하였다. Propolis 추출물은 농도 의존적으로 난소암 세포의 증식을 억제했으며. Flow cytometric 분석을 통해 G0/G1기에서 세포 주기 억제와 apoptosis 유도 효과를 확인하였다. 이러한 결과는 Austalian propolis의 인간 난소암에 대한 예방과 치료를 위한 보조제로서의 가능성을 제시한다.

Propolis is a natural product collected from plants by honey bees product used extensively in traditional medicine for its antioxidant, anti-inflammatory, immunomodulatory and anti-cancer effects. Propolis exhibits a broad spectrum of biological activities because it is a complex mixture of natural substances. Ovarian cancer is the second most common newly diagnosed cancer from all cancers among women in Korea and the leading cause of death from gynecological malignancies. While most ovarian cancer patients initially respond to surgical debulking and chemotherapy, patients later succumb to the disease. Thus, there is an urgent need to test novel therapeutic agents to counteract the high mortality rate associated with ovarian cancer. In this study, we investigated the anti-cancer properties and the active mechanism of Australian propolis in human epithelial ovarian cancer A2780 cells. Our data revealed that propolis showed a cytotoxic activity in a dose-dependent manner. Flow cytometric analysis for cell cycle arrest and apoptosis using propidium iodide staning and annexin V-FITC indicated that propolis could induce cycle arrest in the G0/G1 phase and apoptosis in a dose-dependent manner on human epithelial ovarian cancer cells. These results suggest that the Australian propolis is potential alternative agent on ovarian cancer prevention and treatment.

키워드

참고문헌

  1. Alencar, S. M., Oldoni, T. L., Castro, M. L., Cabral, I. S., Costa-Neto, C. M., Cury, J. A., Rosalen, P. L. and Ikegaki, M. 2007. Chemical composition and biological activity of a new type of Brazilian propolis: red propolis. J. Ethnoph. 113, 278-283. https://doi.org/10.1016/j.jep.2007.06.005
  2. Aletti, G. D., Gallenberg, M. M., Cliby, W. A., Jatoi, A. and Hartmann, L. C. 2007. Current management strategies for ovarian cancer. Mayo Clin. Proc. 82, 751-770. https://doi.org/10.1016/S0025-6196(11)61196-8
  3. Ashkenazi, A. 2008. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev. 19, 325-331. https://doi.org/10.1016/j.cytogfr.2008.04.001
  4. Awale, S., Li, F., Onozuka, H., Esumi, H., Tezuka, Y. and Kadota, S. 2008. Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition. Bioorg. Med. Chem. 16, 181-189. https://doi.org/10.1016/j.bmc.2007.10.004
  5. Banskota, A. H., Tezuka, Y. and Kadota, S. 2001. Recent progress in pharmacological research of propolis. Phytother. Res. 15, 561-571. https://doi.org/10.1002/ptr.1029
  6. Bast, R. C. 2003. Status of tumor markers in ovarian cancer screening. J. Clin. Oncol. 21, 200-205. https://doi.org/10.1200/JCO.2003.01.068
  7. Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M. and Huang, D. C. 2005. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell. 17, 393-403. https://doi.org/10.1016/j.molcel.2004.12.030
  8. Choi, Y. M., Noh, D. O., Cho, S. Y., Suh, H. J., Kim, K. M. and Kim, J. M. 2006. Antioxidant and antimicrobial activities of propolis from several regions of Korea. LWT-Food Sci. Technol. 39, 756-761. https://doi.org/10.1016/j.lwt.2005.05.015
  9. Clarke, P. G. and Clarke, S. 1995. Historic apoptosis. Nature 16, 230.
  10. Ferlini, C., Raspaglio, G., Mozzetti, S., Distefano, M., Filippetti, F., Martinelli, E., Ferrandina, G., Gallo, D., Ranelletti, F. O. and Scambia, G. 2003. Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance. Mol. Pharmacol. 64, 51-58. https://doi.org/10.1124/mol.64.1.51
  11. Fulda, S., Gorman, A. M., Hori, O. and Samali, A. 2010. Cellular stress responses: cell survival and cell death. Int. J. Cell Biol. 2010, 214074.
  12. Gottesman, M. M. 2002. Mechanisms of cancer drug resistance. Annu. Rev. Med. 53, 615-627. https://doi.org/10.1146/annurev.med.53.082901.103929
  13. Greenaway, W., May, J., Scaysbrook, T. and Whatley, F. R. 1991. Identification by gas chromatography-mass spectrometry of 150 compounds in propolis. Z. Naturforsch. C 46, 111-121.
  14. Hunter, T. and Pines, J. 1994. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79, 573-582. https://doi.org/10.1016/0092-8674(94)90543-6
  15. Jasprica, I., Bojic, M., Mornar, A., Besic, E., Bucan, K. and Medic-Saric, M. 2007. Evaluation of antioxidative activity of croatian propolis samples using DPPH. and ABTS.+ stable free radical assays. Molecules 12, 1006-1021. https://doi.org/10.3390/12051006
  16. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T. and Thun, M. J. 2008. Cancer statistics, 2008. CA Cancer J. Clin. 58, 71-96. https://doi.org/10.3322/CA.2007.0010
  17. Jung, B. I., Kim, M. S., Kim, H. A., Kim, D., Yang, J., Her, S. and Song, Y. S. 2010. Caffeic acid phenethyl ester, a component of beehive propolis, is a novel selective estrogen receptor modulator. Phytother. Res. 24, 295-300.
  18. Kalil, N. G. and McGuire, W. P. 2002. Chemotherapy for advanced epithelial ovarian carcinoma. Best Pract. Res. Clin. Obstet. Gynaecol. 16, 553-571. https://doi.org/10.1053/beog.2002.0307
  19. Vermeulen, K., Van Bockstaele, D. R. and Berneman, Z. N. 2004. The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 36, 131-149.
  20. Kim, A., Ueda, Y., Naka, T. and Enomoto, T. 2012. Therapeutic strategies in epithelial ovarian cancer. J. Exp. Clin. Cancer Res. 31, 14. https://doi.org/10.1186/1756-9966-31-14
  21. Lee, H. S., Lee, J. Y., Kim, D. C., In, M. J. and Hwang, W. I. 2000. The inhibitory effects of propolis on in vitro proliferation of human cancer cell lines. Kor. J. Nutr. 33, 80-85.
  22. Li, F., Awale, S., Tezuka, Y. and Kadota, S. 2010. Cytotoxicity of constituents from Mexican propolis against a panel of six different cancer cell lines. Nat. Prod. Commun. 5, 1601-1606.
  23. Liu, Z., Zhu, G., Getzenberg, R. H. and Veltri, R. W. 2015. The upregulation of PI3K/Akt and MAP kinase pathways is associated with resistance of microtubule‐targeting drugs in prostate cancer. J. Cell Biochem. 116, 1341-1349. https://doi.org/10.1002/jcb.25091
  24. Meher, P. K. and Mishra, K. P. 2017. Radiation oxidative stress in cancer induction and prevention. J. Radiat. Cancer Res. 8, 44-52. https://doi.org/10.4103/jrcr.jrcr_10_17
  25. Mozzetti, S., Ferlini, C., Concolino, P., Filippetti, F., Raspaglio, G., Prislei, S., Gallo, D., Martinelli, E., Ranelletti, F. O., Ferrandina, G. and Scambia, G. 2005. Class III ${\beta}$-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin. Cancer Res. 11, 298-305.
  26. Pichichero, E., Cicconi, R., Mattel, M., Muzi, M. G. and Canini, A. 2010. Acacia honey and chrysin reduce proliferation of melanoma cells through alterations in cell cycle progression. Int. J. Oncol. 37, 973-981.
  27. Piver, M. S. 2005. 16,090: the 2004 estimated US mortality from ovarian cancer. Gyneco. Oncol. 97, 301-302. https://doi.org/10.1016/j.ygyno.2004.12.044
  28. Sabatier, S., Amiot, M. J., Tacchini, M. and Aubert, S. 1992. Identification of flavonoids in sunflower honey. J. Food Sci. 57, 773-774. https://doi.org/10.1111/j.1365-2621.1992.tb08094.x
  29. Sawicka, D., Car, H., Borawska, M. H. and Niklinski, J. 2012. The anticancer activity of propolis. Folia Histochem. Cytobiol. 50, 25-37. https://doi.org/10.5603/FHC.2012.0004
  30. Seidman, J. D., Cho, K. R., Ronnett, B. M. and Kurman, R. J. 2011. Surface epithelial tumors of the ovary. In Blaustein's pathology of the female genital tract, pp. 679-784, 6th ed., Springer US.
  31. Sforcin, J. M. 2007. Propolis and the immune system: a review. J. Ethnopharmacol. 113, 1-14. https://doi.org/10.1016/j.jep.2007.05.012
  32. Song, Y. H., Huh, H. Y., Kim, C. S. and Kim, K. J. 1997. Effects of propolis and caffeic acid phenethyl ester on tumorigenesis, pulmonary metastases, and activities of splenocytes and macrophages in mice. Kor. J. Immunol. 19, 617-628.
  33. Szliszka, E., Czuba, Z. P., Bronikowska, J., Mertas, A., Paradysz, A. and Krol, W. 2011. Ethanolic extract of propolis augments TRAIL-induced apoptotic death in prostate cancer cells. Evid. Based Complement. Alternat. Med. 2011, 535172.
  34. Willis, S. N., Fletcher, J. I., Kaufmann, T., van Delft, M. F., Chen, L., Czabotar, P. E., Ierino, H., Lee, E. F., Fairlie, W. D., Bouillet, P., Strasser, A., Kluck, R. M., Adams, J. M. and Strasser, A. 2007. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315, 856-859. https://doi.org/10.1126/science.1133289
  35. Zhuang, Y. and Miskimins, W. 2008. Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27 Kip1 or p21 Cip1. J. Mol. Signal. 3, 18. https://doi.org/10.1186/1750-2187-3-18
  36. Zhang, L., An, R., Wang, J., Sun, N., Zhang, S., Hu, J. and Kuai, J. 2005. Exploring novel bioactive compounds from marine microbes. Curr. Opin. Microbiol. 8, 276-281. https://doi.org/10.1016/j.mib.2005.04.008